|Noubar Afeyan (Founder & Chief executive officer)|
Flagship Pioneering is an American life sciences company based in Cambridge, Massachusetts that founds biotechnology, life sciences, health and sustainability companies, including the biotechnology company Moderna. The firm is known for funding companies that it creates and incubates in-house.
The company was founded in Cambridge in 1999 by Noubar Afeyan under the name NewcoGen (short for "new company generation"). A few years later, the name was changed to Flagship Ventures, and again in 2016 to Flagship Pioneering.
- Fry, Erika (May 19, 2020). "How the biotech investor behind Moderna is using the 'immigrant mindset' to take on COVID-19". Fortune.
- Stendahl, Max (December 15, 2016). "A new name and new fund will ensure Cambridge's Flagship 'feels like a startup'". Boston Business Journal.
- Saltzman, Jonathan (April 2, 2020). "VC firm Flagship Pioneering raises $1.1b for biotech startups, despite reeling economy". Boston Globe.
- Dunn, Andrew (May 23, 2020). "The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time". Business Insider.
- DeAngelis, Allison (April 2, 2020). "With $1.1B in hand, life sciences investor Flagship rewrites its rulebook". Boston Business Journal.
- Garde, Damian (November 10, 2020). "The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race". Stat.
This article "Flagship Pioneering" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.